EBUS-TBNA is useful not only for proper staging and diagnosis of lung cancer, but also to obtain samples for mutation analysis of NSCLC after EGFR-TKI, as demonstrated in this study. This evidence concerns the gene EGFR and non-small cell lung carcinoma.